Spots Global Cancer Trial Database for Metformin Treatment of Pregnant Women With Polycystic Ovary Syndrome: a Pilot Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Metformin Treatment of Pregnant Women With Polycystic Ovary Syndrome: a Pilot Study
Official Title: Metformin Treatment of Pregnant Women With Polycystic Ovary Syndrome: a Pilot Study
Study ID: NCT03259919
Conditions
Study Description
Brief Summary: To investigate the effect of metformin on pregnancy complications and pregnancy outcome in the II. and III. trimester of pregnancy in women with polycystic ovary syndrome.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Departments of Obstetrics and Gynecology and Endocrinology, St. Olav's Hospital, Trondheim, , Norway
Contact Details
Name: Sven M Carlsen, MD, PhD
Affiliation: Norwegian University of Science and Technology
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
